Αποτελέσματα Αναζήτησης
In March 1987, AZT became the first drug to gain approval from the U.S. Food and Drug Administration for treating AIDS. AZT, also referred to as zidovudine, belongs to a class of drugs known as nucleoside reverse transcriptase inhibitors, or NRTIs.
27 Αυγ 2009 · Within 25 years after zidovudine (3′-azido-2′,3′-dideoxythymidine, AZT) was first described as an inhibitor of HIV replication, 25 anti-HIV drugs have been formally approved for clinical use in the treatment of HIV infections: seven nucleoside reverse transcriptase inhibitors (NRTIs): zidovudine, didanosine, zalcitabine, stavudine ...
19 Μαρ 2017 · The first AIDS drug was approved on March 19, 1987—but getting there was by no means easy. Here's the story behind the treatment.
Zidovudine (ZDV), also known as azidothymidine (AZT), was the first antiretroviral medication used to prevent and treat HIV/AIDS. It is generally recommended for use in combination with other antiretrovirals. [ 6 ]
Abstract. Within 25 years after zidovudine (3'-azido-2',3'-dideoxythymidine, AZT) was first described as an inhibitor of HIV replication, 25 anti-HIV drugs have been formally approved for clinical use in the treatment of HIV infections: seven nucleoside reverse transcriptase inhibitors (NRTIs): zidovudine, didanosine, zalcitabine, stavudine, ...
The human immunodeficiency virus (HIV) was identified as the cause of acquired immunodeficiency syndrome (AIDS) in 1984, and the first treatment for the disease, AZT, was approved by the U.S. Food and Drug Administration in 1987.
9 Σεπ 2010 · AZT, also called Zidovudine (ZVD) and Retrovir, was the first approved HIV/AIDS drug. It is a reverse transcriptase inhibitor. This type of medicine stops the reproduction of DNA and reduces the amount of the virus in the blood (the viral load). AZT samples in the museum’s collections. AZT was approved by the FDA on March 19, 1987.
